CD200R1L
gene geneOn this page
Also known as CD200RLaCD200R2
Summary
CD200R1L (CD200 receptor 1 like, HGNC:24665) is a protein-coding gene on chromosome 3q13.2, encoding Cell surface glycoprotein CD200 receptor 2 (Q6Q8B3). May be a receptor for the CD200/OX2 cell surface glycoprotein.
Predicted to enable signaling receptor activity. Predicted to be involved in regulation of neuroinflammatory response. Predicted to be located in cell surface and membrane. Predicted to be active in external side of plasma membrane.
Source: NCBI Gene 344807 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 49 total — 1 pathogenic
- MANE Select transcript:
NM_001199215
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24665 |
| Approved symbol | CD200R1L |
| Name | CD200 receptor 1 like |
| Location | 3q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CD200RLa, CD200R2 |
| Ensembl gene | ENSG00000206531 |
| Ensembl biotype | protein_coding |
| Entrez | 344807 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000398214, ENST00000486723, ENST00000488794
RefSeq mRNA: 3 — MANE Select: NM_001199215
NM_001008784, NM_001199215, NM_001370552
CCDS: CCDS43131, CCDS56267
Canonical transcript exons
ENST00000488794 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001853039 | 112846625 | 112846864 |
| ENSE00003480962 | 112845679 | 112845950 |
| ENSE00003528729 | 112829319 | 112829384 |
| ENSE00003616893 | 112826993 | 112827241 |
| ENSE00003658369 | 112819772 | 112819895 |
| ENSE00003658627 | 112827367 | 112827684 |
| ENSE00003660693 | 112837942 | 112838010 |
| ENSE00003936316 | 112815711 | 112815975 |
Expression profiles
Bgee: expression breadth broad, 28 present calls, max score 87.79.
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.41 | gold quality |
| testis | UBERON:0000473 | 56.57 | gold quality |
| left testis | UBERON:0004533 | 56.37 | gold quality |
| right testis | UBERON:0004534 | 55.12 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 51.69 | gold quality |
| monocyte | CL:0000576 | 49.03 | gold quality |
| leukocyte | CL:0000738 | 48.46 | gold quality |
| duodenum | UBERON:0002114 | 40.08 | gold quality |
| bone marrow cell | CL:0002092 | 38.86 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 37.17 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow | UBERON:0002371 | 35.57 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.05 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 34.65 | silver quality |
| muscle tissue | UBERON:0002385 | 33.65 | gold quality |
| vermiform appendix | UBERON:0001154 | 33.42 | silver quality |
| blood | UBERON:0000178 | 33.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| frontal cortex | UBERON:0001870 | 31.85 | gold quality |
| endometrium | UBERON:0001295 | 31.26 | silver quality |
| primary visual cortex | UBERON:0002436 | 31.15 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 30.11 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| right uterine tube | UBERON:0001302 | 29.51 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 29.45 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.27 |
| E-GEOD-110499 | no | 6.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting CD200R1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-3136-3P | 99.57 | 66.59 | 781 |
| HSA-MIR-7155-3P | 99.57 | 66.48 | 794 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-629-5P | 98.78 | 68.72 | 1032 |
| HSA-MIR-6794-3P | 98.76 | 66.99 | 894 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-5585-3P | 98.25 | 67.41 | 941 |
| HSA-MIR-6511A-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-6511B-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-6802-5P | 94.94 | 65.95 | 366 |
| HSA-MIR-135A-3P | 94.19 | 66.09 | 495 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cd200r1 | ENSMUSG00000022667 |
| mus_musculus | Cd200r3 | ENSMUSG00000036172 |
| mus_musculus | Cd200r4 | ENSMUSG00000062082 |
| mus_musculus | Cd200r2 | ENSMUSG00000090176 |
| rattus_norvegicus | Cd200r1l | ENSRNOG00000002046 |
| rattus_norvegicus | Cd200r1 | ENSRNOG00000039048 |
Paralogs (1): CD200R1 (ENSG00000163606)
Protein
Protein identifiers
Cell surface glycoprotein CD200 receptor 2 — Q6Q8B3 (reviewed: Q6Q8B3)
Alternative names: CD200 cell surface glycoprotein receptor-like 2, CD200 cell surface glycoprotein receptor-like a, Cell surface glycoprotein CD200 receptor 1-like, Cell surface glycoprotein OX2 receptor 2
All UniProt accessions (2): Q6Q8B3, F8WDF0
UniProt curated annotations — full annotation on UniProt →
Function. May be a receptor for the CD200/OX2 cell surface glycoprotein.
Subcellular location. Membrane.
Similarity. Belongs to the CD200R family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6Q8B3-1 | 1 | yes |
| Q6Q8B3-2 | 2 |
RefSeq proteins (3): NP_001008784, NP_001186144, NP_001357481 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007110 | Ig-like_dom | Domain |
| IPR013162 | CD80_C2-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR040012 | CD200R | Family |
Pfam: PF08205
UniProt features (16 total): glycosylation site 6, topological domain 2, domain 2, signal peptide 1, chain 1, disulfide bond 1, splice variant 1, sequence variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6Q8B3-F1 | 83.50 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 160–209
Glycosylation sites (6): 92, 189, 217, 30, 39, 86
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GOBP_INFLAMMATORY_RESPONSE, GOCC_CELL_SURFACE, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_DEFENSE_RESPONSE, GOCC_SIDE_OF_MEMBRANE, GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE, GOBP_NEUROINFLAMMATORY_RESPONSE, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN, GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP, GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP, GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP, GSE13547_WT_VS_ZFX_KO_BCELL_UP
GO Biological Process (1): regulation of neuroinflammatory response (GO:0150077)
GO Molecular Function (2): signaling receptor activity (GO:0038023), protein binding (GO:0005515)
GO Cellular Component (3): external side of plasma membrane (GO:0009897), cell surface (GO:0009986), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| regulation of inflammatory response | 1 |
| neuroinflammatory response | 1 |
| molecular transducer activity | 1 |
| binding | 1 |
| plasma membrane | 1 |
| cell surface | 1 |
| side of membrane | 1 |
Protein interactions and networks
STRING
140 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CD200R1L | CD200 | P41217 | 588 |
| CD200R1L | TYROBP | O43914 | 535 |
| CD200R1L | SIRPA | P78324 | 426 |
| CD200R1L | CD200R1 | Q8TD46 | 399 |
| CD200R1L | DOK2 | O60496 | 355 |
| CD200R1L | TIGD2 | Q4W5G0 | 324 |
| CD200R1L | CPA6 | Q8N4T0 | 312 |
| CD200R1L | ZNF816 | Q0VGE8 | 306 |
| CD200R1L | CLVS1 | Q8IUQ0 | 297 |
| CD200R1L | PCNX2 | A6NKB5 | 270 |
| CD200R1L | TAS2R50 | P59544 | 269 |
| CD200R1L | CD101 | Q93033 | 252 |
| CD200R1L | IL18R1 | Q13478 | 225 |
| CD200R1L | MAMSTR | Q6ZN01 | 224 |
| CD200R1L | CACNA2D4 | Q7Z3S7 | 220 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CD200R1L | NKX3-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD200R1L | IGSF10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| NKX3-1 | CD200R1L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): CD200R1L (Two-hybrid), CD200R1L (Affinity Capture-MS)
ESM2 similar proteins: A0A0E4BZH1, A4QPC6, A5D7V5, A7TZE6, A7TZF0, A7TZF3, A7XUX6, A7XV04, A7XV07, A8K4G0, A8MVZ5, O70355, P08508, P18892, P24071, P31994, P55803, P78410, P79391, Q13410, Q16653, Q29ZQ1, Q3KPI0, Q58DF9, Q5R7W8, Q5R960, Q5R996, Q61885, Q62556, Q63345, Q6Q8B3, Q6UXZ3, Q6XJV4, Q6XJV6, Q7KYR7, Q7TST0, Q7YR73, Q8BTP3, Q8K249, Q8TD46
Diamond homologs: A5D7V5, Q2YHT5, Q2YHT7, Q5R412, Q5UKY4, Q6Q8B3, Q6XJV4, Q6XJV6, Q7Z3B1, Q80Z24, Q8BTP3, Q8TD46, Q9ES57, Q9ES58, Q9W6V2, Q9Z0J8, A2AJ76, Q8NDA2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 980050 | GRCh37/hg19 3q13.2-13.31(chr3:112135341-115509260)x3 | Pathogenic |
SpliceAI
1174 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:112827242:C:CC | acceptor_gain | 1.0000 |
| 3:112827626:G:T | acceptor_gain | 1.0000 |
| 3:112822214:T:TA | donor_gain | 0.9900 |
| 3:112827237:TGTAA:T | acceptor_gain | 0.9900 |
| 3:112827238:GTAA:G | acceptor_gain | 0.9900 |
| 3:112827239:TAA:T | acceptor_gain | 0.9900 |
| 3:112827240:AA:A | acceptor_gain | 0.9900 |
| 3:112827241:AC:A | acceptor_loss | 0.9900 |
| 3:112827242:C:CG | acceptor_loss | 0.9900 |
| 3:112827625:CGA:C | acceptor_gain | 0.9900 |
| 3:112827627:A:C | acceptor_gain | 0.9900 |
| 3:112845677:A:AC | donor_gain | 0.9900 |
| 3:112845678:C:CC | donor_gain | 0.9900 |
| 3:112826987:GCTT:G | donor_loss | 0.9800 |
| 3:112826988:CTTA:C | donor_loss | 0.9800 |
| 3:112826989:TTACC:T | donor_loss | 0.9800 |
| 3:112826990:TACC:T | donor_loss | 0.9800 |
| 3:112826991:ACCT:A | donor_loss | 0.9800 |
| 3:112826992:CCT:C | donor_loss | 0.9800 |
| 3:112827245:C:CT | acceptor_gain | 0.9800 |
| 3:112827362:CTTAC:C | donor_loss | 0.9800 |
| 3:112827364:T:TA | donor_loss | 0.9800 |
| 3:112827365:A:AA | donor_loss | 0.9800 |
| 3:112827366:C:CT | donor_loss | 0.9800 |
| 3:112845672:GACTT:G | donor_loss | 0.9800 |
| 3:112845673:ACTT:A | donor_loss | 0.9800 |
| 3:112845674:CTT:C | donor_loss | 0.9800 |
| 3:112845675:TTA:T | donor_loss | 0.9800 |
| 3:112845676:T:TG | donor_loss | 0.9800 |
| 3:112845678:CCAGA:C | donor_gain | 0.9800 |
AlphaMissense
1620 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:112827395:G:C | F134L | 0.793 |
| 3:112827395:G:T | F134L | 0.793 |
| 3:112827397:A:G | F134L | 0.793 |
| 3:112827596:C:A | W67C | 0.752 |
| 3:112827596:C:G | W67C | 0.752 |
| 3:112827155:A:G | W173R | 0.712 |
| 3:112827155:A:T | W173R | 0.712 |
| 3:112819795:G:C | F260L | 0.691 |
| 3:112819795:G:T | F260L | 0.691 |
| 3:112819797:A:G | F260L | 0.691 |
| 3:112827153:C:A | W173C | 0.691 |
| 3:112827153:C:G | W173C | 0.691 |
| 3:112827497:C:A | W100C | 0.684 |
| 3:112827497:C:G | W100C | 0.684 |
| 3:112827033:A:C | H213Q | 0.680 |
| 3:112827033:A:T | H213Q | 0.680 |
| 3:112827084:A:C | S196R | 0.677 |
| 3:112827084:A:T | S196R | 0.677 |
| 3:112827086:T:G | S196R | 0.677 |
| 3:112827219:A:C | F151L | 0.673 |
| 3:112827219:A:T | F151L | 0.673 |
| 3:112827221:A:G | F151L | 0.673 |
| 3:112827462:A:G | I112T | 0.666 |
| 3:112827160:A:G | I171T | 0.653 |
| 3:112827499:A:G | W100R | 0.640 |
| 3:112827499:A:T | W100R | 0.640 |
| 3:112819792:G:C | F261L | 0.619 |
| 3:112819792:G:T | F261L | 0.619 |
| 3:112819794:A:G | F261L | 0.619 |
| 3:112827598:A:G | W67R | 0.616 |
dbSNP variants (sampled 300 via entrez): RS1000126481 (3:112833735 A>G), RS1000141494 (3:112822115 A>G), RS1000220356 (3:112846621 G>A), RS1000234528 (3:112840264 G>A,C), RS1000301610 (3:112820632 T>C), RS1000369959 (3:112820337 T>C), RS1000428543 (3:112821812 T>A), RS1000856188 (3:112825925 T>G), RS1001310793 (3:112828520 A>G), RS1001485782 (3:112836909 A>G), RS1001549820 (3:112820359 T>A,G), RS1001696407 (3:112843304 A>G), RS1001929797 (3:112823966 A>C,G), RS1002001437 (3:112843618 A>G), RS1002010641 (3:112846214 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST012049_5 | High density lipoprotein cholesterol levels | 6.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.